Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Immucor, Inc.
Immucor CEO's Italian Trial Moves Toward Second Phase
May 3rd, 2008
Immucor, Inc., (NASDAQ:BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, announced the first level of the Italian court case against CEO Gioacchino "Nino" De Chirico has concluded and will now move to the second level. The tribunal in Milan rendered a guilty verdict in the first-level trial based on an alleged improper cash payment of euro 13,500 by Immucor's Italian subsidiary to a physician. The Italian criminal court system is much different from the U.S. system, and consists of three different levels. At the first and second levels both sides can present evidence and legal arguments; at the third level only...
Source: Law & Health Weekly (2008-05-03)
|
